Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Combining SVF and PRP speeds up wound healing.

Natural volatiles and essential oils have health benefits and can enhance the effects of some medicines, but more research is needed to understand how they work and their possible side effects.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

PLD is an effective and safer alternative for treating breast cancer.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

The botanical treatment for hair loss shows promise, especially for children.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

The drug combination was safe and showed promise in treating advanced tumors.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Drug metabolism affects how long a drug works, its interactions, activation, and toxicity, and is influenced by genetics, diet, illness, and other drugs.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.